Enovis Corp. (ENOV)
24.32
-1.47
(-5.70%)
USD |
NYSE |
Mar 05, 16:00
24.32
0.00 (0.00%)
After-Hours: 20:00
Enovis Cash from Investing (Quarterly) : -12.99M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -34.91M |
| Twist Bioscience Corp. | -9.933M |
| Abbott Laboratories | -913.00M |
| Accuray, Inc. | -5.596M |
| Plus Therapeutics, Inc. | 1.297M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 88.54M |
| Cash from Financing (Quarterly) | -72.92M |
| Free Cash Flow | 19.92M |
| Free Cash Flow Per Share (Quarterly) | 0.5646 |
| Free Cash Flow to Equity (Quarterly) | 94.01M |
| Free Cash Flow to Firm (Quarterly) | 52.77M |
| Free Cash Flow Yield | 1.43% |